130 related articles for article (PubMed ID: 12230360)
1. Long-term outcome in lupus nephritis.
Spiera RF; Homel P; Spiera H
Ann Intern Med; 2002 Sep; 137(6):545-6; author reply 545-6. PubMed ID: 12230360
[No Abstract] [Full Text] [Related]
2. The treatment of lupus nephritis: revisiting Galen.
Lewis EJ
Ann Intern Med; 2001 Aug; 135(4):296-8. PubMed ID: 11511144
[No Abstract] [Full Text] [Related]
3. Summaries for patients. Kidney disease in patients with lupus who are treated with potent drugs that suppress the immune system.
Ann Intern Med; 2001 Aug; 135(4):S-29. PubMed ID: 11529202
[No Abstract] [Full Text] [Related]
4. [Treatment of nephritis in systemic lupus erythematodes].
Ligtenberg G; Derksen RH; Berden JH
Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1941-4. PubMed ID: 8927179
[No Abstract] [Full Text] [Related]
5. Treatment of proliferative lupus nephritis: a changing landscape.
Adu D
Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
[TBL] [Abstract][Full Text] [Related]
6. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT
Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
[TBL] [Abstract][Full Text] [Related]
11. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
12. Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis.
Vachvanichsanong P; Dissaneewate P; McNeil E
Int Urol Nephrol; 2013 Oct; 45(5):1301-8. PubMed ID: 23225077
[TBL] [Abstract][Full Text] [Related]
13. [Interdisciplinary consensus to management of lupus nephritis in Germany].
de Groot K
Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
15. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
[No Abstract] [Full Text] [Related]
16. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century].
Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA
Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523
[No Abstract] [Full Text] [Related]
17. Efficacy of low-dose versus high-dose cyclophosphamide in lupus nephritis: comment on the article by Houssiau et al.
Block JA
Arthritis Rheum; 2003 May; 48(5):1466; author reply 1466-7. PubMed ID: 12746929
[No Abstract] [Full Text] [Related]
18. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
19. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cortés-Hernández J; Ordi-Ros J; Labrador M; Segarra A; Tovar JL; Balada E; Vilardell-Tarres M
Lupus; 2003; 12(4):287-96. PubMed ID: 12729052
[TBL] [Abstract][Full Text] [Related]
20. [Results of treatment of lupus nephritis in children. Own experience].
Kwinta-Rybicka J; Sancewicz-Pach K
Pol Merkur Lekarski; 2000 Apr; 8(46):232-4. PubMed ID: 10897625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
